🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the immune response and the safety of a primary series schedule...
Status
Completed
Location
Multiple Locations
Start Date
2013-05-01
Trial ID
NCT01839188
Treatments Being Tested
The purpose of this study is to evaluate safety and immunogenicity of Pedia...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT00343421
Treatments Being Tested
The purpose of the study is to provide data on the safety and immunogenicit...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00355654
Treatments Being Tested
The objective for this study is to characterize the safety profile of PENTA...
Status
Completed
Location
Multiple Locations
Start Date
2008-09
Trial ID
NCT00804284
Treatments Being Tested
Pediacel™ is currently licensed in the UK for use as a 3 dose regimen for t...
Status
Completed
Location
Multiple Locations
Start Date
2006-02
Trial ID
NCT00287092
Treatments Being Tested
The study will evaluate the safety, immunogenicity，immune persistence and l...
Status
Active Not Recruiting
Location
Neihuang County Center for Disease Control and Prevention
Start Date
2021-10-22
Trial ID
NCT05091619
Treatments Being Tested
Pertussis, diphtheria and tetanus are seriously infectious diseases in chil...
Status
Completed
Location
Changge Center for Disease Control and Prevention
Start Date
2020-04-28
Trial ID
NCT04099303
Treatments Being Tested
This is a follow-up of Study A3L11 (NCT00404651). Immunogenicity * To des...
Status
Completed
Location
Multiple Locations
Start Date
2008-03
Trial ID
NCT00654901
The purpose of this study is to evaluate the safety and immunogenicity of t...
Status
Recruiting
Location
Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention
Start Date
2023-12-21
Trial ID
NCT06344065
Treatments Being Tested
This Phase III, open-label, randomized, parallel-group, active-controlled, ...
Status
Completed
Location
Multiple Locations
Start Date
2016-11-07
Trial ID
NCT03205371
Treatments Being Tested